Related Experiment Video
Updated: Jun 4, 2025
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
213
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice
Rachel Hodan1, Samir Gupta2, Jennifer M Weiss3
1Stanford Cancer Institute.
Journal of the National Comprehensive Cancer Network : JNCCN
|December 17, 2024
Summary
Multigene panel testing identifies cancer risks, guiding endometrial cancer (EC) screening and management for high-risk individuals. Updates include CHEK2 variant screening changes for colon cancer prevention.
Area of Science:
- Oncology
- Genetics
- Cancer Screening
Background:
- Multigene panel testing detects inherited variants increasing cancer risk, including endometrial cancer (EC).
- Key hereditary syndromes linked to EC are Lynch syndrome, PTEN hamartoma tumor syndrome, and Peutz-Jeghers syndrome.
- NCCN Guidelines offer updated recommendations for genetic/familial high-risk assessment.
Purpose of the Study:
- To present the latest NCCN Guidelines for EC screening and management in high-risk patients.
- To discuss the benefits and drawbacks of multigene panel testing.
- To detail recent guideline updates on de-implementing colon cancer screening for CHEK2 variants.
Main Methods:
- Review of the NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric.
- Analysis of current evidence on multigene panel testing utility.
- Examination of updated data on CHEK2 variants and colon cancer risk.
Main Results:
- NCCN Guidelines provide updated recommendations for EC screening and management based on hereditary cancer syndromes.
- Multigene panel testing offers comprehensive genetic insights but has limitations.
- New evidence supports de-implementation of colon cancer screening for certain CHEK2 variants.
Conclusions:
- Adherence to updated NCCN Guidelines is crucial for optimal EC management in high-risk populations.
- Understanding multigene panel testing's advantages and limitations aids clinical decision-making.
- Evidence-based guideline revisions, like those for CHEK2, refine cancer screening protocols.
Related Concept Videos
02:59Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
01:33Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K